A detailed history of B & T Capital Management Dba Alpha Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, B & T Capital Management Dba Alpha Capital Management holds 3,289 shares of LLY stock, worth $2.89 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
3,289
Previous 3,073 7.03%
Holding current value
$2.89 Million
Previous $2.72 Million 6.72%
% of portfolio
0.5%
Previous 0.55%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

BUY
$727.2 - $932.06 $157,075 - $201,324
216 Added 7.03%
3,289 $2.54 Million
Q3 2024

Oct 09, 2024

BUY
$772.14 - $960.02 $2.09 Million - $2.6 Million
2,711 Added 748.9%
3,073 $2.72 Million
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $262,402 - $329,072
362 New
362 $327,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $835B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track B & T Capital Management Dba Alpha Capital Management Portfolio

Follow B & T Capital Management Dba Alpha Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B & T Capital Management Dba Alpha Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on B & T Capital Management Dba Alpha Capital Management with notifications on news.